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Bronchospasm in obese patients 
undergoing elective laparoscopic surgery 
under general anesthesia
Vassilios Tassoudis1, Hronis Ieropoulos1, Menelaos Karanikolas2*, George Vretzakis1, Aik Bouzia3, 
Elias Mantoudis1 and Argyro Petsiti1
Abstract 
Background: Existing data suggest that obesity correlates with airway hyper-reactivity. However, the incidence of 
bronchospasm during bariatric surgery in obese patients has not been well studied.
Methods: This was a prospective observational study comparing 50 obese versus 50 non obese patients undergo-
ing elective laparoscopic surgery over a 2 year period. Bronchospasm was detected clinically by auscultation and was 
confirmed by measuring peak airway pressure during mechanical ventilation. Blood gases were measured at prede-
termined time intervals intraoperatively. Categorical variables were analyzed using Fisher’s exact test, while numerical 
variables within and between groups were compared using repeated measures general linear model.
Results: The incidence of bronchospasm was significantly higher in obese compared to non obese patients 
(P = 0.027). Peak airway pressures and blood gases differed significantly when comparing non obese patients versus 
obese patients without bronchospasm versus obese patients with bronchospasm. Hypoventilation resulting in 
gradual increase of arterial PaCO2 was noted in all groups during surgery.
Conclusion: The incidence of bronchospasm is higher in obese patients compared to non obese patients undergo-
ing elective laparoscopic surgery. Airway pressures and blood gas values in obese patients are somewhere between 
values in non obese patients and values in patients with bronchospasm, thereby implying that obesity is associated 
with a state where bronchial smooth muscles are not fully relaxed. Consideration of increased airway reactivity in 
obese patients undergoing laparoscopic surgery is important for improved patient care and uneventful anesthetic 
course.
Keywords: Obesity, Bronchospasm, Laparoscopic surgery, Bariatric surgery, Airway, Oxygenation, Airway, 
Complications
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Background
Published clinical data show that obesity is a risk factor 
for development of bronchial asthma (Camargo et  al. 
1999; Guerra et al. 2004; Kim and Camargo 2003; Luder 
et  al. 2004; Schachter et  al. 2001; Shore and Fredberg 
2005; Weiss and Shore 2004). Seventy-five per cent of 
patients visiting emergency departments for bronchial 
asthma crisis are obese (Thomson et  al. 2003), and 
weight loss has been documented to decrease the rate 
and severity of symptoms of bronchial asthma in obese 
patients (Aaron et  al. 2004). Surgical interventions that 
result in weight loss in obese patients are associated 
with improved airway function (Macgregor and Rand 
1993; Dixon et  al. 1999), and obesity is associated with 
small airway hyperexcitability both in animals and in 
humans (Litonjua et al. 2002). Three theories attempt to 
describe the underlying mechanism of the spasm of air-
way smooth muscles and its consequential airway nar-
rowing. According to the first theory spasm is caused by 
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static and elastic forces which are enhanced in obesity, 
due to small lung volumes and reduced functional resid-
ual capacity (FRC) (Yap et  al. 1995; Damia et  al. 1988; 
Pelosi et al. 1997; Ding et al. 1987; Fredberg 2000; Gump 
et al. 2001; Sampson and Grassino 1983). However, this 
argument has been questioned by experimental data 
showing increased airway responsiveness resulting in 
bronchospasm in obese compared with lean mice, even 
when the mechanical load from excessive adipose tissue 
is eliminated by opening the chest wall and the lungs are 
exposed to ozone (Shore et al. 2003). The second expla-
nation concerns anatomic differences leading to differ-
ent lung growth (remodeling) between obese and normal 
children (Shore and Fredberg 2005; Aaron et  al. 2004; 
Shore et  al. 2003). Nevertheless, not all obese people 
were obese during childhood. The third theory implicates 
an inflammatory microenvironment that promotes air-
way narrowing in response to adipocyte-derived factors 
causing inflammation and bronchial irritation (Rajala and 
Scherer 2003; Hotamisligil 2003; Nawrocki and Scherer 
2004; Chen et al. 2003).
Published data show that the incidence of postopera-
tive complications is higher in obese surgical patients, 
and these complications range from minor complica-
tions, such as vomiting to major complications, such as 
myocardial ischemia and long term complications, such 
as wound disruption (Watcha and White 1992; Shenk-
man et al. 1993; Herrara et al. 1999). The risk of intraop-
erative respiratory complications, such as hypoxemia, is 
higher in obese adult patients (Hofer et  al. 2008; Dun-
can et al. 1992; Chung et al. 1999) and in obese pediatric 
patients (El-Metainy et al. 2011) compared to non-obese 
patients. However, despite these concerns, obese patients 
can safely have ambulatory surgery (Hofer et  al. 2008) 
and, with appropriate care and preventive measures, the 
number and severity of complications is low (Choban and 
Flancbaum 1997; Dindo et al. 2003; Thomas et al. 1997).
Based on the above observations, we designed a pro-
spective observational study of adult patients undergoing 
elective abdominal laparoscopic surgery under general 
anesthesia, in an attempt to evaluate bronchospasm in 
obese patients undergoing laparoscopic bariatric surgery 
versus non-obese patients undergoing other laparoscopic 
general surgery procedures.
Methods
This prospective observational study enrolled one hun-
dred patients undergoing elective laparoscopic abdomi-
nal surgery under general anesthesia, divided in two 
groups: One group included 50 patients with normal 
to excess body weight (BMI  <  35  kg/m2, group A) who 
underwent elective laparoscopic cholecystectomy, her-
nia repair or colectomy. These patients were compared 
with a group of 50 patients with severe to morbid obesity 
(BMI ≥ 35 kg/m2, group B) who underwent laparoscopic 
sleeve gastrectomy.
Patients were offered the option of participating in the 
study, based on timing of their surgery (“first come, first 
serve”). Enrollment in each group continued until enough 
patients consented to reach the predetermined goal of 
enrolling 50 patients per group. This was a prospective 
observational study, and therefore there was no randomi-
zation and no “blinding” issues. The study was approved 
by the Institution Ethics Committee, was conducted at a 
tertiary care University Hospital over a 2 year period, and 
was registered at the “Clinical Trials” international trial 
registry (ClinicalTrials.gov Identifier: NCT01488643).
Sample size calculation was conducted before the study 
started, using the G*Power Version 3.1.9 sample size 
calculation program, which is freely available from the 
University of Dusseldorf, in Germany. Sample size calcu-
lation was based on the following assumptions: Primary 
outcome is the presence of bronchospasm, and expected 
bronchospasm incidence is 15 % in obese patients versus 
0.5  % in healthy non-obese patients. In obese patients, 
the incidence of asthma has been reported in a range 
from as low as 10–12  % (Beuther and Sutherland 2007; 
Luder et  al. 2004) to as high as 35  % (Schachter et  al. 
2001). Therefore, we believe that bronchospasm inci-
dence of 15  %, which is the basis of our power analysis 
is reasonable, because it is supported not only by our 
unpublished data, but also by earlier published stud-
ies. Based on these assumptions, sample size calculation 
showed that, for alpha error  =  0.05, our study would 
need 48 patients (rounded to 50 patients) per group in 
order to have beta error = 0.2, therefore for the study to 
have power = 1 − b = 0.8.
Initial evaluation of obese patients for inclusion in 
the study was done at their first scheduled preoperative 
assessment. Inclusion criteria were written informed 
consent and age > 18 years. Exclusion criteria were his-
tory of psychiatric disease or mental disorder, use of 
marijuana or other habit-forming drugs and inability to 
follow preoperative orders. All patients were instructed 
to quit smoking at least 8  weeks before scheduled sur-
gery. On admission to the hospital, patients were asked if 
they followed preoperative instructions and quit smoking 
before their operation (Warner 2006). All patients stated 
they quit smoking at least 2  months (=8  weeks) before 
surgery. All patients were evaluated with standardized 
anesthetic preoperative assessment (The Association of 
Anaesthetists of Great Britain and Ireland 2007). This 
was important because morbidly obese patients can 
have profound cardio-respiratory dysfunction which 
remains asymptomatic due to limited mobility. Preopera-
tive assessment also included screening for obstructive 
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sleep apnea (OSA), which is common in morbidly obese 
patients and can predispose to hypoventilation, difficult 
mask ventilation, shunt with rapid arterial oxygen desatu-
ration. In addition, OSA warrants particular attention 
during emergence from anesthesia, extubation and in the 
immediate postoperative period.
In addition, when pre-anesthesia evaluation raised 
concerns for potential difficult airway, patients were also 
evaluated by ENT (Ear Nose and Throat) surgeon using 
flexible endoscopy to assess airway patency and poten-
tial for difficult mask ventilation and/or endotracheal 
intubation. Demographic and clinical data, including 
age, sex, height, weight, body mass index (BMI), ASA 
physical status, tobacco use and comorbidities, including 
hypertension, asthma, chronic obstructive pulmonary 
disease (COPD) and OSA were collected and stored in a 
secure encrypted computer. Data were collected by phy-
sicians trained in data collection, and were immediately 
reviewed by a senior investigator to confirm data com-
pleteness, consistency and reliability.
In the operating room monitoring included five lead 
ECG and continuous arterial blood pressure monitoring 
after insertion of radial arterial line. All study partici-
pants were informed about placement of a radial arterial 
line just for the purposes of this study. Allen’s test was 
performed in all patients before proceeding with radial 
artery catheterization.
Anesthesia was induced with intravenous (IV) mida-
zolam 2  mg, propofol 3  mg/kg and fentanyl 150 mcg. 
After ability to manually ventilate was confirmed, cisa-
tracurium 0.2 mg/kg was given to facilitate endotracheal 
intubation. All medication doses were calculated based 
on ideal body weight. Anesthesia was maintained with 
sevoflurane at 1.2 end-tidal MAC (corrected for age) 
combined with fentanyl and remifentanil.
The Drager Primus anesthetic workstation (Drager, Inc, 
Lubeck, Germany) was used for all cases. This worksta-
tion has a sophisticated ventilator that can provide dif-
ferent modes of ventilation, including volume control 
and pressure control ventilation. Mechanical ventila-
tion was standardized using the following settings: Vol-
ume Control mode, tidal volume 6 ml/kg based on ideal 
body weight, inspiratory O2 fraction (FiO2) 0.5, posi-
tive end expiratory pressure (PEEP) 5  cm H2O, inspira-
tory to expiratory ratio 1:2 with 10 % plateau, and target 
Pmax  ≤  30  cm H2O. Muscle relaxation was monitored 
with quantitative TOF-determination (TOF Watch; 
Organon, Dublin, Ireland), whereby TOF ratio <0.9 indi-
cated reversal of neuromuscular blockade. Pneumop-
eritoneum pressure was up to 12–13 mmHg, in order to 
maintain consistent intraoperative intraabdominal pres-
sure in all patients. Multimodal analgesia was initiated 
20  min before the end of surgery with combination of 
IV morphine 5 mg and IV paracetamol 1 gm. Postopera-
tive analgesia included tramadol 100 mg IV twice a day, 
paracetamol 600 mg IV four times a day and rescue mor-
phine 2–5 mg IV for 3 days.
In order to standardize diagnosis and treatment during 
the study, the diagnosis of bronchospasm was based on 
intense wheezing detected by auscultation. Other signs 
supporting the diagnosis of bronchospasm were tidal vol-
ume reduction (hypoventilation), increased circuit pres-
sure and prolonged expiration with visible upslope on 
the capnogram due to increased airway resistance, arte-
rial blood oxygen desaturation and hypoventilation. End-
tidal CO2 values measured with waveform capnography 
are not reliable for diagnosis of bronchospasm, because 
they can rise due to hypoventilation, but can also fall 
in cases of severe bronchospasm due to insufficient gas 
exchange. Therefore, we obtained repeated arterial blood 
gas samples in order to measure PaCO2 and PaO2 as 
markers of hypoventilation and arterial blood desatura-
tion, rather than rely solely on expired gas measurement.
The study protocol instructed the anesthesiologist to 
start treatment with bronchodilators as soon as bron-
chospasm was confirmed. The protocol also suggested 
avoiding airway irritation due to extensive manipula-
tion, light anesthesia, endotracheal tube misplacement, 
aspiration or other stimuli that could lead to bronchial 
irritation and spasm. In cases where bronchospasm was 
suspected, the anesthesiologist was instructed to (a) 
check the endotracheal tube for narrowing/obstruction 
by kinking or secretions, (b) look for rashes that could 
be manifestation of allergic reaction, (c) check for cya-
nosis or desaturation to ensure that oximetry signals are 
valid, and (d) attempt to ventilate manually while listen-
ing for breath sounds and observing airway pressures. 
Peak and plateau pressures were measured together 
to help detect what the problem was: elevation of both 
peak and plateau pressures is more likely caused by 
intrathoracic cause (bronchospasm), whereas isolated 
peak airway pressure increase without change in plateau 
pressure could indicate a problem at or proximal to the 
ETT, such as mechanical tube narrowing (Stenqvist et al. 
1979). If bronchospasm was detected, treatment options 
included increasing FiO2 to 100  % to improve oxygena-
tion, b2-receptor agonists or b1, b2 mixed agonists, cor-
ticosteroids and methyl xanthenes in order to achieve 
bronchodilation.
Peak pressure and arterial blood gas values were 
recorded at pre-defined time points throughout the peri-
operative period. During pneumoperitoneum, data were 
collected 10, 30 and 50 min after onset of the pneumop-
eritoneum, and these time points are reported as T1, T2 
and T3, respectively. Data were analyzed using the SPSS 
v.17 statistical software package (SPSS Inc., Chicago, IL). 
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For analysis purposes, patients were divided in 2 groups, 
based on whether they had (1) or not (0) a characteris-
tic for each independent variable. Groups were assigned 
to obese patients (1), non obese (0), and to patients with 
(1) or without bronchospasm (0). Categorical variables 
were compared using Chi square or Fisher’s exact test, as 
appropriate. Repeated Measures General Linear Model 
analysis was used to detect statistical differences between 
groups and within groups at different time points. 
Observed differences were considered significant when 
P < 0.05.
Results
In total, our study enrolled 100 patients (54 women, 46 
men), and mean age was 44.5  years. Patients were allo-
cated into two groups (50 obese patients vs. 50 non obese 
patients) using BMI value of 35 kg/m2 as the cut-off point. 
Mean BMI was 46.32  ±  6.97  kg/m2 (morbid obesity 
≥40 kg/m2) in obese patients versus 28.34 ± 3.31 kg/m2 
in non obese patients. Mean ASA value was 3.16 ± 0.37 
in obese versus 2.01 ± 0.57 in non obese patients. There 
was no significant difference between the groups with 
regards to cigarette smoking (P = 0.671) or hypertension 
(P = 0.833). In the obesity group, 2 patients had known 
bronchial asthma (ns) and 24 patients had known OSA 
(P < 0.001). All patients completed the study, there were 
no cases with missing data, and the results are summa-
rized in Table 1.
Six patients had intraoperative bronchospasm, and all 
six belonged in the obese group (6/50 vs. 0/50; P = 0.027 
by Fisher’s exact test). These patients were then analyzed 
as a subgroup among patients with obesity. In all cases, 
bronchospasm was detected immediately after induction 
of anesthesia and persisted despite all treatment efforts 
at least until the time of the third measurement (T3) or 
until the end of surgery. Peak airway pressure, PaCO2, 
and PaO2 data at sampling times T1, T2 and T3 from 
non-obese patients versus obese patients without bron-
chospasm versus the subgroup of obese patients with 
bronchospasm are presented in Figs. 1, 2 and 3, respec-
tively. With regards to peak airway pressure, compari-
son between groups showed gradual increase in values, 
denoting that peak pressure in obese patients is higher 
than in non-obese patients. Furthermore, peak airway 
Table 1 Demographic and clinical patient characteristics
Continuous variables are reported as Mean ± SD. Values are compared using t 
test, Chi square test or Fisher’s exact test as appropriate
Obese (n = 50) Non obese (n = 50) P
Males/females 16/34 30/20 0.009
Age (years) 40.96 ± 9.67 48 ± 16.89 0.012
ASA status 3.16 ± 0.37 2.01 ± 0.57 0.000
Weight (kg) 132.44 ± 17.82 79.88 ± 6.59 0.000
BMI (kg/m2) 46.322 ± 6.976 28.347 ± 3.31 0.000
Smoking 18 15 NS
Bronchial asthma 2 0 NS
Obstructive sleep apnea 24 0 0.000
Hypertension 16 18 NS
























Fig. 1 Airway pressure values (Mean, SD) over time in non-obese 
patients versus obese patients without bronchospasm versus obese 
patients with bronchospasm. Between groups comparisons showed 
significantly (P = 0.000) higher airway pressures in obese compared 
to non-obese patients, and significantly (P = 0.01) higher airway pres-
sures in patients with bronchospasm compared to patients without 
bronchospasm at all time points. Within groups comparisons did not 
show significant changes of airway pressures over time (P = 0.08)





















Fig. 2 Arterial blood gas PaCO2 values (Mean, SD) in non-obese 
patients versus obese patients without bronchospasm versus obese 
patients with bronchospasm over time. Between groups compari-
sons showed significantly (P = 0.005) higher PaCO2 values in obese 
compared to non-obese patients, and significantly (P = 0.012) higher 
PaCO2 values in patients with bronchospasm compared to patients 
without bronchospasm at all time points. Within groups comparisons 
showed significant (P = 0.015) change of PaCO2 values over time, as 
seen in the graph
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pressure in obese patients with bronchospasm was higher 
compared to obese patients without bronchospasm 
(Fig.  1). PaCO2 measurements showed a similar pat-
tern whereby ventilation was best in non-obese patients, 
lower (hypoventilation) in obese patients without bron-
chospasm, and even lower (worst) in obese patients with 
bronchospasm (Fig. 2). PaO2 values showed a similar pat-
tern, with gradual decline between groups insinuating 
that hypoventilation and airway restriction lead to grad-
ual arterial blood desaturation; however, the last PaO2 
value was elevated (sampling time T3; 163 ± 21 mmHg, 
Fig. 3) because FiO2 was increased in an attempt to treat 
hypoxemia.
Discussion
Our observation that bronchospasm is a clinically rel-
evant issue in obese patients undergoing bariatric lapa-
roscopic surgery, together with the paucity of data on 
the subject motivated us to conduct this prospective 
observational study. Our results showed high incidence 
of bronchospasm (6 of 50, 12 %) in obese patients, which 
is significantly higher compared to the incidence in non-
obese patietns (0 of 50, 0 %, P = 0.027). There is no clear 
understanding why the incidence of bronchospasm was 
higher in obese patients. However, it is plausible that, 
because of increased bronchial excitability, common air-
way irritants can trigger bronchospasm in obese patients, 
but not necessarily in non-obese patients whose bron-
chial smooth muscle is not as prone to spasm.
As expected, patients developing bronchospasm 
showed significant differences regarding airway pres-
sures and PaCO2 with hypoventilation and deterioration 
of arterial blood PaO2 values. However, because FiO2 was 
increased from 50 to 100 % in order to maintain adequate 
oxygenation in patients with bronchospasm, PaO2 val-
ues cannot support any safe conclusions with regards to 
oxygenation. Both variables indicate that gradual smooth 
muscle constriction leads to increasing airway resistance 
which, in turn, leads to hypoventilation and high airway 
pressures due to airway narrowing. Arterial blood oxy-
gen levels followed a reverse pattern compared to airway 
pressures and PaCO2: the augmented PaO2 value at time 
point T3 was not surprising because the attending anes-
thesiologist increased FiO2 from 0.5 to 1 in order to main-
tain adequate arterial oxygen saturation. Our analysis did 
not show significant airway pressure changes over the 
entire surgical procedure, thereby suggesting that time 
in itself did not have a significant effect on airway pres-
sures. Between groups analysis showed that obesity was 
a significant factor, and there were differences in blood 
gas and airway pressure values between obese versus non 
obese patients, as mentioned above. Patients with bron-
chospasm had significantly higher airway pressure and 
PaCO2 values compared to patients without bronchos-
pasm. However, differences in PaO2 values did not reach 
statistical significance, because FiO2 adjustments aimed 
at maintaining adequate saturation by oximetry affected 
PaO2 values in patients with bronchospasm.
Within groups comparisons did not show a signifi-
cant interaction between time and airway pressures. The 
observation that airway pressures did not change signifi-
cantly over time suggests that bronchospasm occurred 
early during the case, and treatment did not result in 
measurable improvement. In contrast, arterial blood 
gas values showed significant time effect: hypoventi-
lation occurred in all groups and persisted over time, 
even though ventilation was still considered satisfactory, 
whereas oxygenation worsened and resulted in desatura-
tion over time only in obese patients with bronchospasm. 
Bariatric surgery patients may be more susceptible to 
hypoventilation and impaired oxygenation, because gen-
eral anesthesia and pneumoperitoneum can exaggerate 
the respiratory dysfunction already present in morbid 
obesity. General anesthesia reduces FRC by up to 20 % in 
healthy individuals and by up to 50  % in obese patients 
(Bjerkedal 1957). However, we cannot attribute this effect 
to bronchospasm, because airway pressures did not 
change significantly over time. There was no obvious syn-
ergistic effect over time in obese patients with regards to 
airway pressure, PaCO2 or PaO2, meaning that no vari-
able changed more over time in the obese group. As dis-
cussed earlier, because the observed synergistic effect of 




















Fig. 3 Arterial blood gas PaO2 values (Mean, SD) in non-obese 
patients versus obese patients without bronchospasm versus obese 
patients with bronchospasm over time. Between groups compari-
sons showed significantly (P = 0.000) lower PaO2 values in obese 
compared to non-obese patients at all time points. Although PaO2 
values were lower in patients with, compared to patients without 
bronchospasm, the difference did not reach significance (P = 0.305). 
Within groups comparisons showed significant (P = 0.000) change of 
PaO2 values over time, as seen in the graph
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PaO2 over time in patients with bronchospasm was due 
to increasing FiO2, this finding cannot support any valid 
conclusions.
In our study, the obese patient group had higher ASA 
physical status compared to non-obese patients, but this 
difference was expected because of the higher number 
of comorbidities in obese patients, and is in agreement 
with earlier studies (Bjerkedal 1957; Adams and Mur-
phy 2000). Morbidly obese patients with high propor-
tion of visceral fat are at increased risk for cardiovascular 
disease, left ventricular dysfunction, hypertension and 
stroke, and have higher incidence of OSA. In our sam-
ple, obese patients were relatively young and there was 
no association between obesity and smoking or bronchial 
asthma, despite the fact that obesity is a possible con-
tributor to asthma, as discussed in the introduction. It is 
possible that our study design and small sample size did 
not have adequate power to demonstrate the association 
between obesity, smoking and hyper reactive airways.
The use of morphine in patients with pre-existing 
asthma or intraoperative bronchospasm could be sub-
ject to criticism. However, published data suggest that 
morphine is well tolerated, and may even be beneficial 
in patients with asthma (Soleymani et  al. 1972; Blum-
berg 1973; Eschenbacher et  al. 1984; Rutherford et  al. 
2002; Otulana et al. 2004). Furthermore, because hydro-
morphone is not available for clinical use in Greece, 
morphine and meperidine were the only medium-long 
acting opioids available for use in our patients. We there-
fore chose to use morphine for analgesia because this is 
the opioid most frequently used in our clinical setting, 
and also due to concerns about the adverse effects of 
meperidine.
The absence of preoperative pulmonary function data 
is a limitation of this study. However, current guidelines, 
including the latest guidelines on the perioperative man-
agement of the obese surgical patient that were published 
in 2015 do not require preoperative pulmonary function 
testing in obese patients undergoing surgery (Nightingale 
et al. 2015).
Morbid obesity probably defines a special category 
of patients with unique pathophysiologic changes and 
increased risk of perioperative complications. Obese 
people are affected by several serious, potentially life 
threatening health issues, including respiratory morbid-
ity which worsens during laparoscopic surgery. Com-
pared to patients with normal-weight, obese patients 
have increased metabolic needs, hypervolemia due to 
higher extracellular volume, increased cardiac output 
and enlarged pulmonary vascular system (Adams and 
Murphy 2000). These changes can result in increased 
lung resistance and decreased compliance, thereby 
contributing to hypoventilation and arterial blood 
desaturation. In agreement with the literature regarding 
obese awake individuals (Shore and Fredberg 2005), the 
increased airway pressures and PaCO2 and decreased 
PaO2 between groups observed in our study suggest 
that obese patients undergoing laparoscopic surgery 
are in a “pre-bronchospasm state” and therefore are 
prone to bronchospasm. This “pre-bronchospasm state” 
could be the consequence of chronic lung inflammation. 
Elevated serum cytokines, chemokines and adipocyte 
derived factors, such as leptin, adiponectin and plas-
minogen activator inhibitor are potential factors that 
could result in chronic sensitization of smooth mus-
cles, thereby altering bronchial smooth muscle function 
and promoting airway narrowing. These considera-
tions emphasize the importance of careful planning of 
the anesthetic technique for morbidly obese patients 
undergoing laparoscopic surgery. Even though these are 
“routine operations” from the surgeon’s point of view, 
the anesthesiologist should be vigilant about potential 
problems and carefully plan the anesthetic regimen, in 
order to reduce the risk of perioperative respiratory or 
other adverse events and optimize patient well being.
In conclusion, perioperative bronchospasm is a sig-
nificant issue in obese patients undergoing laparoscopic 
surgery. As the diagnosis of bronchospasm is based on 
peak airway pressure and blood gas changes, record-
ing of baseline values is essential. Because of increased 
smooth muscle irritability, bariatric patients are likely 
to be in a “pre-bronchospasm state”, with airway pres-
sure values somewhere between values observed in non 
obese patients and values observed in obese patients with 
known bronchospasm. More studies on large number of 
patients are needed to clarify the role of bronchospasm 
and its effect on postoperative respiratory function and 
outcome in obese patients undergoing laparoscopic 
surgery.
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